The U.S. Food and Drug Administration has approved Indianapolis-based Eli Lilly's new treatment for moderate to severe eczema ...

Eli Lilly's long-term growth prospects are strong with improved supply, new growth opportunities, and competitive positioning ...

In a report released yesterday, Alec Stranahan from Bank of America Securities maintained a Buy rating on Eli Lilly & Co (LLY – ...

Wells Fargo analyst Mohit Bansal assigned a Buy rating on Eli Lilly & Co (LLY – Research Report) yesterday and set a price target of ...

Collaboration between giant pharmaceutical corporations and patients with very little power just doesn’t work, according to ...

We recently compiled a list of the 10 Best Counter Cyclical and Defensive Stocks to Invest In. In this article, we are going ...

Novo Nordisk has multiple, strong upcoming, positive catalysts, related to its GLP-1 weight-loss drugs, Ozempic and Wegovy.

Cabarrus and Charlotte leaders, students and Eli Lilly and Company representatives were on hand Friday, Sept. 6, to celebrate ...

The Journal sat down with Colleen Dixon, the new CEO of Spokane-based Selkirk Pharma Inc., to discusswhat the company has been up to in the last couple of years and what Dixon is focused on ...

The late-stage clinical trial results showed that Eli Lilly’s once-weekly insulin efsitora matched daily injections for ...